
Health & Medicine
COVID-19 is still a threat, but getting a vaccine is harder for many people
Vaccination is still important to ward off the worst of the coronavirus. Three experts discuss the concerns with restricting access.
Every print subscription comes with full digital access
Vaccination is still important to ward off the worst of the coronavirus. Three experts discuss the concerns with restricting access.
We summarize the week's scientific breakthroughs every Thursday.
Dropping vaccination rates and changes in U.S. vaccine policy have public health experts concerned that annual measles outbreaks could become more frequent.
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.
The Teal Wand, an at-home HPV testing device that could replace a Pap smear, could broaden access to cervical cancer screening.
News of NIH funding cuts have trickled out in recent months. A new study tallies what’s been terminated.
The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.
Researchers are still divided about whether Spinosaurus was a swimmer or a wader. What’s clear is that confirming the first swimming dinosaur would be a game-changer.
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.
Not a subscriber?
Become one now.